Metabolic fate of TE-031 (A-56268) (I): Comparative pharmacokinetics of TE-031 and erythromycin stearate in rats and mice

CHEMOTHERAPY

Volumn 36, Issue , 1988, Pages 198-204

  Suwa, Toshio ^a   Yoshida, Hideo ^a   Fukushima, Kiyomi ^a   Nagate, Takatoshi ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN;

ANIMAL EXPERIMENT; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG TISSUE LEVEL; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RAT;

EID: 0023788696     PISSN: 00093165     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1953.36.Supplement3_198     Document Type: Article

References (7)

1. 14, 38 (4): 395-414, 1980.
2. Lazarevski, T.; G. Radobolja & S. Djokic: Erythromycin VI: Kinetics of Acid-Catalyzed Hydrolysis of Erythromycin Oxime and Erythromycylamine. J. Pharm. Sci. 67: 1031-1033, 1978.
3. Morimoto, S.; Y. Takahashi, Y. Watanabe & S. Omura Chemical Modification of Erythromycins L Synthesis and Antibacterial Activity of 6-O-methyl-erythromycin A. J. Antibiot. 37: 187-189, 1984.
4. Josamycin VI. Jpn. J. Antibiot, 22: 226-231, 1969.
5. Lee, C.C.: R.C. Anderson & K.K. Chen: Tissue Distribution of Erythromycin in Rats. Antibiot. Chemother. 3: 920-924, 1953.
6. TMS-19-Q. Chemotherapy 32 (S-6): 93-98, 1984.
7. Syomura, T. & K. Umemura: Studies of Absorption, Distribution, Metabolism and Excretion of a New Macrolide Antibiotic SF-837 I. Chem. Pharm. Bull. 21 (8): 1824-1831, 1973.